| Name | microRNA 5193 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nmiR-5193 has recently been identified as a potent antiviral microRNA with the capacity to target hepatitis B virus (HBV) transcripts across multiple genotypes. By establishing a highly stable hybridization with HBV RNA, miR-5193 significantly decreases luciferase reporter activity and surface antigen production, indicating its promise as a therapeutic tool to inhibit HBV replication."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "1"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn the realm of prostate cancer, miR-5193 has been shown to exert a tumor‐suppressive role by directly targeting the mRNA encoding TRIM11—a pro‐tumorigenic E3 ubiquitin ligase. Overexpression of miR-5193 in prostate cancer cells leads to the downregulation of TRIM11, which in turn correlates with reduced cell proliferation and a potentially more favorable clinical outcome."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "2"}]}, {"type": "t", "text": ""}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nSimilarly, in ovarian cancer, miR-5193 functions as an essential inhibitor of tumor progression. It directly targets TRIM11, resulting in decreased expression of this oncogene. This targeting is accompanied by the upregulation of key tumor suppressors such as p53 and p21, ultimately leading to cell cycle arrest, increased apoptosis, and diminished migratory and proliferative capabilities in ovarian cancer cells. These findings not only reinforce the role of miR-5193 in modulating oncogenic pathways but also suggest its potential utility as a downstream regulator in the carcinogenic processes mediated by factors like FUT1."}, {"type": "fg", "children": [{"type": "fg_f", "ref": "3"}]}, {"type": "t", "text": ""}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Apichaya Khlaiphuengsin, Nattanan Panjaworayan T-Thienprasert, Pisit Tangkijvanich, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Human miR-5193 Triggers Gene Silencing in Multiple Genotypes of Hepatitis B Virus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Microrna (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2174/2211536604666150819195743"}], "href": "https://doi.org/10.2174/2211536604666150819195743"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26456535"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26456535"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Yue Pan, Riyan Zhang, Hongde Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Expression of Tripartite Motif-Containing Proteactiin 11 (TRIM11) is Associated with the Progression of Human Prostate Cancer and is Downregulated by MicroRNA-5193."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Med Sci Monit (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.12659/MSM.911818"}], "href": "https://doi.org/10.12659/MSM.911818"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30608062"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30608062"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Zuofei Song, Qian Guo, Huimin Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-5193, regulated by FUT1, suppresses proliferation and migration of ovarian cancer cells by targeting TRIM11."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2020.153148"}], "href": "https://doi.org/10.1016/j.prp.2020.153148"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32823233"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32823233"}]}]}]}
|
| Synonyms | MIR-5193 |
| NCBI Gene ID | 100847079 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR5193 has 380 functional associations with biological entities spanning 4 categories (molecular profile, functional term, phrase or reference, cell line, cell type or tissue, gene, protein or microRNA) extracted from 9 datasets.
Click the + buttons to view associations for MIR5193 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR5193 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR5193 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR5193 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR5193 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of MIR5193 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of MIR5193 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR5193 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR5193 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| WikiPathways Pathways 2014 | pathways involving MIR5193 protein from the Wikipathways Pathways 2014 dataset. | |